Consenso colombiano de hepatitis C. Conferencias
Colombian consensus of hepatitis C. Conferences
Barra lateral del artículo
PDF
FLIP
Cómo citar
de Medicina y Cirugía, R. R. (2002). Consenso colombiano de hepatitis C. Conferencias. Revista Repertorio De Medicina Y Cirugía, 11(1), 8–38. https://doi.org/10.31260/RepertMedCir.v11.n1.2002.270
Sección
Artículo de revisión
Términos de Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Contenido principal del artículo
Palabras clave:
Descargas
Los datos de descargas todavía no están disponibles.
Detalles del artículo
Referencias
1. Alter H. Natural history and clinical aspects of hepatitis C virus infection. In Schinazi, Sommadossi, Thomas, Therapies for Viral Hepatitis. International Medical Press, 1" edition. Pg: 43-50. 1998
2. Wilber J. New development in hepatitis C diagnostics and monitoring. en: Schinazi, Sommadossi, Thomas Therapies for Viral Hepatitis. International Medical Press, I" edition. Pg: 133- 138. 1998
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the U.S. N. Engl J Med. 1992; 327: 1899-1905.
4. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion- associated non A, non B hepatitis. N Engl J Med. 1992. 327:1906-1911.
5. Poynard T, Bedossa P, Opoler P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997; 349:825-832.
6. Tong MJ, el-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332:1463-1466.
7. Younossi Z, Mc Hutchinson J. Serological tests for HCV infection. Viral Hepatitis Reviews. 1996; 2:161-173.
8. Fattovich G, Giusting G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C. Gastroenterology. 1997; 112:463-472.
9. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a separate reduction in quality of life in the absence of cirrhosis. Hepatology. 1998; 27: 209-212.
10. Shiffman ML. Management of hepatitis C. Clinical perspectives in Gastroenterology. 1998; 5: 6-19.
2. Wilber J. New development in hepatitis C diagnostics and monitoring. en: Schinazi, Sommadossi, Thomas Therapies for Viral Hepatitis. International Medical Press, I" edition. Pg: 133- 138. 1998
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the U.S. N. Engl J Med. 1992; 327: 1899-1905.
4. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion- associated non A, non B hepatitis. N Engl J Med. 1992. 327:1906-1911.
5. Poynard T, Bedossa P, Opoler P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997; 349:825-832.
6. Tong MJ, el-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332:1463-1466.
7. Younossi Z, Mc Hutchinson J. Serological tests for HCV infection. Viral Hepatitis Reviews. 1996; 2:161-173.
8. Fattovich G, Giusting G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C. Gastroenterology. 1997; 112:463-472.
9. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a separate reduction in quality of life in the absence of cirrhosis. Hepatology. 1998; 27: 209-212.
10. Shiffman ML. Management of hepatitis C. Clinical perspectives in Gastroenterology. 1998; 5: 6-19.
Citado por
